Sfoglia per AUTORE
GILESTRO M
Collezione AOU Città della Salute di Torino

  

Items : 12

Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia. in Leukemia / Leukemia. 2023 Feb;37(2):388-395. doi: 10.1038/s41375-022-01762-3. Epub 2022 Nov 26.
2023
AOU Città della Salute di Torino

Vos JMI; Fend F; Kyriakou C; Morel P; Poulain S; Roccaro AM; Willenbacher W; Kaš?ák M; D'Sa S; Kersten MJ; Kastritis E; Leblond V; Tedeschi A; Jurczak W; Owen R; García-Álvarez M; Gilestro M; Puig N; Drandi D; Pérez J; Ferrante M; Bagratuni T; Varettoni M; Talaulikar D; Jiménez C; Dogliotti I; Dimopoulos MA; Buske C; Ferrero S; et alii...

High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 Sep 20;40(27):3120-3131. doi: 10.1200/JCO.21.01393. Epub 2022 Jun 6.
2022
AOU Alessandria
AOU Città della Salute di Torino

Musto P; Boccadoro M; Gay F; Belotti A; Tacchetti P; Fazio F; Zambello R; Luppi M; Liberati AM; Palmieri S; Annibali O; Monaco F; Galieni P; Pisani F; Capra A; Gilestro M; Curci P; Pascarella A; Tosi P; De Sabbata G; Pietrantuono G; Gentile M; Ledda A; Paris L; Morè S; Corradini P; Rota-Scalabrini D; Oliva S; Bertamini L; et alii...

Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial. in Blood cancer journal / Blood Cancer J. 2021 Jun 3;11(6):106. doi: 10.1038/s41408-021-00498-0.
2021
AOU Città della Salute di Torino

Oliva S; Bruinink DHO; Rihova L; D'Agostino M; Pantani L; Capra A; van der Holt B; Troia R; Petrucci MT; Villanova T; Vsianska P; Jugooa R; Brandt-Hagens C; Gilestro M; Offidani M; Ribolla R; Galli M; Hajek R; Gay F; Cavo M; Omedé P; van der Velden VHJ; Boccadoro M; Sonneveld P;

A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma. in Annals of hematology / Ann Hematol. 2021 Feb;100(2):437-443. doi: 10.1007/s00277-020-04384-w. Epub 2021 Jan 3.
2021
AOU Città della Salute di Torino

Oliva S; De Paoli L; Ruggeri M; Caltagirone S; Troia R; Oddolo D; D'Agostino M; Gilestro M; Mina R; Saraci E; Margiotta Casaluci G; Genuardi E; Bringhen S; Boccadoro M; Omedé P;

2021
AOU Città della Salute di Torino

Mina R; Bonello F; Petrucci MT; Liberati AM; Conticello C; Ballanti S; Musto P; Olivieri A; Benevolo G; Capra A; Gilestro M; Galieni P; Cavo M; Siniscalchi A; Palumbo A; Montefusco V; Gaidano G; Omedé P; Boccadoro M; Bringhen S;

2019
AOU Città della Salute di Torino

Sonneveld P; Cavo M; Palumbo A; Rocci A; Liberati AM; Offidani M; Gamberi B; Troia R; Bernardini A; Conticello C; Larocca A; Grammatico S; Saraci E; Gilestro M; Muccio VE; Spada S; Omedé P; Gambella M; Boccadoro M; Oliva S; Gambella M; Omedé P; Spada S; Muccio VE; Gilestro M; Saraci E; Grammatico S; Larocca A; Conticello C; et alii...

Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Dec;132:9-16. doi: 10.1016/j.critrevonc.2018.09.008. Epub 2018 Sep 14.
2018
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Gay F; Nagler A; Boccadoro M; Montefusco V; Palumbo A; Ribolla R; Siniscalchi A; Patriarca F; Pezzatti S; De Sabbata G; Di Renzo N; Rizzi R; Gamberi B; Baldini L; Guglielmelli T; Gilestro M; Catalano L; Marcatti M; Spada S; Petrucci MT; Ria R; Offidani M; De Paoli L; Conticello C; D'Agostino M;

Relevance of sample preparation for flow cytometry. in International journal of laboratory hematology / Int J Lab Hematol. 2018 Apr;40(2):152-158. doi: 10.1111/ijlh.12755. Epub 2017 Oct 6.
2018
AOU Città della Salute di Torino

Boccadoro M; Bruno B; Caltagirone S; Ruggeri M; Oddolo D; Gilestro M; Saraci E; Muccio VE; Omedè P;

Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis. in Oncotarget / Oncotarget. 2017 Jan 24;8(4):5924-5935. doi: 10.18632/oncotarget.12641.
2017
AOU Città della Salute di Torino

Caravita T; Conticello C; Liberati AM; Pescosta N; Petrucci MT; Saraci E; Patriarca F; Genuardi M; Bernardini A; Pautasso C; Passera R; Ferrero S; Drandi D; Gay F; Muccio VE; Gilestro M; Gambella M; Oliva S; Rocci A; Musto P; Boccadoro M; Palumbo A; Omedè P;

Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents. in Cytometry. Part B, Clinical cytometry / Cytometry B Clin Cytom. 2016 Jan;90(1):81-90. doi: 10.1002/cyto.b.21279. Epub 2015 Sep 23.
2016
AOU Città della Salute di Torino

Boccadoro M; Palumbo A; Passera R; Marzanati E; Ruggeri M; Astolfi M; Zucchetto A; Gattei V; Gilestro M; Saraci E; Muccio VE; Omedè P;

Clinical impact of immunophenotypic remission after allogeneic hematopoietic cell transplantation in multiple myeloma. in Bone marrow transplantation / Bone Marrow Transplant. 2015 Apr;50(4):511-6. doi: 10.1038/bmt.2014.319. Epub 2015 Feb 9.
2015
AOU Città della Salute di Torino

Giaccone L; Brunello L; Festuccia M; Gilestro M; Maffini E; Ferrando F; Talamo E; Passera R; Boccadoro M; Omedè P; Bruno B;

Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies. in Haematologica / Haematologica. 2014 Oct;99(10):1611-7. doi: 10.3324/haematol.2014.103853. Epub 2014 Jul 11.
2014
AOU Città della Salute di Torino

Caltagirone S; Ruggeri M; Aschero S; Gilestro M; Oddolo D; Gay F; Bringhen S; Musolino C; Baldini L; Musto P; Petrucci MT; Gaidano G; Passera R; Bruno B; Palumbo A; Boccadoro M; Omedè P;